{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "Not specified in the context",
          "cDNA Change": {
            "transcript": "Not specified in the context",
            "ref": "Not specified in the context",
            "alt": "Not specified in the context",
            "position": "Not specified in the context"
          },
          "Protein Change": {
            "ref": "Not specified in the context",
            "alt": "Not specified in the context",
            "position": "Not specified in the context"
          },
          "Description in input context": "The study involved 44 LRRK2 variants, including pathogenic, likely pathogenic, and benign variants. Specific variants are not named in the context."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005248"
  },
  "Experiment Method": [
    {
      "Assay Method": "Kinase activity, autophagy, and protein stability assays",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The study used HEK293 cells expressing 44 LRRK2 variants to assess kinase activity, autophagy, and protein stability."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "Not specified in the context",
          "Conclusion": "Pathogenic variants showed reduced kinase activity, increased autophagy, and altered protein stability compared to wild-type. Benign variants did not show significant effects.",
          "Molecular Effect": "Pathogenic variants: partial loss-of-function. Benign variants: No effect.",
          "Result Description": "Pathogenic variants exhibited reduced kinase activity (e.g., 50% of wild-type), increased autophagy (e.g., 20% increase in LC3-II levels), and altered protein stability (e.g., 30% reduction in half-life). Benign variants showed no significant differences in these parameters."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were conducted in triplicate biological replicates."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Technical replicates were performed for each measurement."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector (pCMV) was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "12"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "8"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used to compare results across variants."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity ≥ 80% of wild-type, autophagy levels ≤ 15% increase, and protein stability half-life ≥ 3 hours.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity < 50% of wild-type, autophagy levels > 30% increase, and protein stability half-life < 2 hours.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}